Concepedia

Guido van Amerongen

GV

15

Publications

533

Citations

14

H-Index

2003

Active since

Affiliations

Centre for Human Drug Research(Current)

Pfizer (United Kingdom)

Leiden University Medical Center

Pfizer (United States)

Janssen (Belgium)

Guido van Amerongen is an author at Centre for Human Drug Research specializing in pain research, pain medicine, and health sciences.

Top concepts

Publications per year

2003–2021

15

Publications

15

Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis

Guido van Amerongen, Kawita M. S. Kanhai, Anne Catrien Baakman et al. · Clinical Therapeutics · 2017 · 78 citations · Full text

, , +14

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Sander Brooks, Gabriël E. Jacobs, Peter de Boer et al. · Journal of Psychopharmacology · 2019 · 69 citations

Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA<sub>A</sub> receptor positive allosteric modulator PF‐06372865

Sarah A. Nickolls, Rachel Gurrell, Guido van Amerongen et al. · British Journal of Pharmacology · 2017 · 59 citations · Full text

Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Na<sub>v</sub>1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects

Pieter Siebenga, Guido van Amerongen, Justin L. Hay et al. · Clinical and Translational Science · 2019 · 52 citations · Full text

A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator

Jonas M. den Heijer, Annelieke C. Kruithof, Guido van Amerongen et al. · British Journal of Clinical Pharmacology · 2021 · 44 citations · Full text

Rows per page

1–5 of 15